Swiss Life Asset Management’s CareDx CDNA Stock Holding History

Swiss Life Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,257	Closed	-$212K	–	1526
2025 Q4	$212K	Buy	+11,257	New	+$189K	﹤0.01%	1244

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Swiss Life Asset Management's CDNA Position: Q1 2026 in Review

Swiss Life Asset Management sold out of CareDx (CDNA) in Q1 2026, closing a stake of 11,257 shares — an estimated $212K sold.

Swiss Life Asset Management first reported a position in CDNA in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

Swiss Life Asset Management reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
Swiss Life Asset Management sold 11,257 CareDx shares in Q1 2026, an estimated $212K.
Swiss Life Asset Management first reported a position in CareDx in Q4 2025 and held it in 1 quarter.
Swiss Life Asset Management's CareDx position peaked at $212K in Q4 2025.
190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Swiss Life Asset Management's 13F filing for Q1 2026, filed 14 May 2026.